{{Rsnum
|rsid=2515641
|Gene=CYP2E1
|Chromosome=10
|position=135351362
|Orientation=plus
|ReferenceAllele=C
|GMAF=0.27
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 74.3 | 25.7 | 0.0
| HCB | 65.0 | 33.6 | 1.5
| JPT | 64.9 | 33.3 | 1.8
| YRI | 9.6 | 51.4 | 39.0
| ASW | 17.5 | 45.6 | 36.8
| CHB | 65.0 | 33.6 | 1.5
| CHD | 77.1 | 22.9 | 0.0
| GIH | 71.3 | 26.7 | 2.0
| LWK | 4.5 | 40.9 | 54.5
| MEX | 69.0 | 24.1 | 6.9
| MKK | 14.1 | 51.9 | 34.0
| TSI | 68.6 | 31.4 | 0.0
| HapMapRevision=28
}}[[rs2515641]] is a SNP in the [[CYP2E1]] gene.

The [[rs2515641]](T) allele defines the CYP2E1_10463T>C(F421F) variant.

{{PMID Auto
|PMID=16385451
|Title=A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.
|OA=1
}}

{{PMID Auto
|PMID=18663376
|Title=Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.
|OA=1
}}

{{PMID Auto
|PMID=19131562
|Title=Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.
|OA=1
}}

{{PMID Auto
|PMID=23460870
|Title=Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}